Authors:
LODGE PA
CHILDS RA
MONAHAN SJ
MCLEAN JG
BOYNTON AL
MURPHY GP
SALGALLER ML
Citation: Pa. Lodge et al., EXPRESSION AND PURIFICATION OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN IN BACULOVIRUS EXPRESSION SYSTEM AND RECOGNITION BY PSMA SPECIFIC T-CELLS, The FASEB journal, 12(5), 1998, pp. 5143-5143
Authors:
SALGALLER ML
LODGE PA
MONAHAN SJ
CHILDS RA
BADER RR
BARREN RJ
ZHOU Y
MCLEAN JG
BOYNTON AL
MURPHY GP
Citation: Ml. Salgaller et al., APPROACHES FOR THE LOADING OF THE SOLUBLE TUMOR-ASSOCIATED ANTIGEN PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INTO DCS FOR THE GENERATION OFMHC CLASS I-RESTRICTED IMMUNE-RESPONSES, Journal of leukocyte biology, 1998, pp. 5-5
Authors:
MURPHY GP
TJOA BA
LODGE PA
SALGALLER ML
BOYNTON AL
Citation: Gp. Murphy et al., ADMINISTRATION OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH PROSTATE-SPECIFIC MEMBRANE ANTIGEN PEPTIDES TO PATIENTS WITH PROSTATE-CANCER, Journal of leukocyte biology, 1998, pp. 16-16
Authors:
KSANDER BR
GEER DC
CHEN PW
SALGALLER ML
RUBSAMEN P
MURRAY TG
Citation: Br. Ksander et al., UVEAL MELANOMAS CONTAIN ANTIGENICALLY SPECIFIC AND NONSPECIFIC INFILTRATING LYMPHOCYTES, Current eye research, 17(2), 1998, pp. 165-173
Authors:
TJOA BA
SIMMONS SJ
BOWES VA
RAGDE H
ROGERS M
ELGAMAL A
KENNY GM
COBB OE
IRETON RC
TROYCHAK MJ
SALGALLER ML
BOYNTON AL
MURPHY GP
Citation: Ba. Tjoa et al., EVALUATION OF PHASE I II CLINICAL-TRIALS IN PROSTATE-CANCER WITH DENDRITIC CELLS AND PSMA PEPTIDES/, The Prostate, 36(1), 1998, pp. 39-44
Authors:
SALGALLER ML
LODGE PA
MCLEAN JG
TJOA BA
LOFTUS DJ
RAGDE H
KENNY GM
ROGERS M
BOYNTON AL
MURPHY GP
Citation: Ml. Salgaller et al., REPORT OF IMMUNE MONITORING OF PROSTATE-CANCER PATIENTS UNDERGOING T-CELL THERAPY USING DENDRITIC CELLS PULSED WITH HLA-A2-SPECIFIC PEPTIDES FROM PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA), The Prostate, 35(2), 1998, pp. 144-151
Citation: Ml. Salgaller et Pa. Lodge, USE OF CELLULAR AND CYTOKINE ADJUVANTS IN THE IMMUNOTHERAPY OF CANCER, Journal of surgical oncology, 68(2), 1998, pp. 122-138
Authors:
CORMIER JN
SALGALLER ML
PREVETTE T
BARRACCHINI KC
RIVOLTINI L
RESTIFO NP
ROSENBERG SA
MARINCOLA FM
Citation: Jn. Cormier et al., ENHANCEMENT OF CELLULAR-IMMUNITY IN MELANOMA PATIENTS IMMUNIZED WITH A PEPTIDE FROM MART-1 MELAN-A, The cancer journal from Scientific American, 3(1), 1997, pp. 37-44
Authors:
CHEN PW
MURRAY TG
SALGALLER ML
KSANDER BR
Citation: Pw. Chen et al., EXPRESSION OF MAGE GENES IN OCULAR MELANOMA CELL-LINES, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 265-275
Citation: Ml. Salgaller, MONITORING OF CANCER-PATIENTS UNDERGOING ACTIVE OR PASSIVE IMMUNOTHERAPY, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 1-14
Authors:
CHEN PW
MURRAY TG
UNO T
SALGALLER ML
REDDY R
KSANDER BR
Citation: Pw. Chen et al., EXPRESSION OF MAGE GENES IN OCULAR MELANOMA DURING PROGRESSION FROM PRIMARY TO METASTATIC DISEASE, Clinical & experimental metastasis, 15(5), 1997, pp. 509-518
Authors:
MARINCOLA FM
RIVOLTINI L
SALGALLER ML
PLAYER T
ROSENBERG SA
Citation: Fm. Marincola et al., DIFFERENTIAL ANTI-MART-1 MELANA CTL ACTIVITY IN PERIPHERAL-BLOOD OF HLA-A2 MELANOMA PATIENTS IN COMPARISON TO HEALTHY DONORS - EVIDENCE OF IN-VIVO PRIMING BY TUMOR-CELLS/, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 266-277
Authors:
MARINCOLA FM
HIJAZI YM
FETSCH P
SALGALLER ML
RIVOLTINI L
CORMIER J
SIMONIS TB
DURAY PH
HERLYN M
KAWAKAMI Y
ROSENBERG SA
Citation: Fm. Marincola et al., ANALYSIS OF EXPRESSION OF THE MELANOMA-ASSOCIATED ANTIGENS MART-1 ANDGP100 IN METASTATIC MELANOMA CELL-LINES AND IN IN-SITU LESIONS, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 192-205
Authors:
PARKHURST MR
SALGALLER ML
SOUTHWOOD S
ROBBINS PF
SETTE A
ROSENBERG SA
KAWAKAMI Y
Citation: Mr. Parkhurst et al., IMPROVED INDUCTION OF MELANOMA-REACTIVE CTL WITH PEPTIDES FROM THE MELANOMA ANTIGEN GP100 MODIFIED AT HLA-A-ASTERISK-0201-BINDING RESIDUES, The Journal of immunology, 157(6), 1996, pp. 2539-2548
Authors:
RIVOLTINI L
LOFTUS DJ
BARRACCHINI K
ARIENTI F
MAZZOCCHI A
BIDDISON WE
SALGALLER ML
APPELLA E
PARMIANI G
MARINCOLA FM
Citation: L. Rivoltini et al., BINDING AND PRESENTATION OF PEPTIDES DERIVED FROM MELANOMA ANTIGENS MART-1 AND GLYCOPROTEIN-100 BY HLA-A2 SUBTYPES - IMPLICATIONS FOR PEPTIDE-BASED IMMUNOTHERAPY, The Journal of immunology, 156(10), 1996, pp. 3882-3891
Authors:
ISHIDA H
MATSUMURA T
SALGALLER ML
OHMIZONO Y
KADONO Y
SAWADA T
Citation: H. Ishida et al., MAGE-1 AND MAGE-3 OR MAGE-6 EXPRESSION IN NEUROBLASTOMA-RELATED PEDIATRIC SOLID TUMORS, International journal of cancer, 69(5), 1996, pp. 375-380
Authors:
SALGALLER ML
MARINCOLA FM
CORMIER JN
ROSENBERG SA
Citation: Ml. Salgaller et al., IMMUNIZATION AGAINST EPITOPES IN THE HUMAN-MELANOMA ANTIGEN GP100 FOLLOWING PATIENT IMMUNIZATION WITH SYNTHETIC PEPTIDES, Cancer research, 56(20), 1996, pp. 4749-4757
Authors:
ALEXANDER M
SALGALLER ML
CELIS E
SETTE A
BARNES WA
ROSENBERG SA
STELLER MA
Citation: M. Alexander et al., GENERATION OF TUMOR-SPECIFIC CYTOLYTIC T-LYMPHOCYTES FROM PERIPHERAL-BLOOD OF CERVICAL-CANCER PATIENTS BY IN-VITRO STIMULATION WITH A SYNTHETIC HUMAN PAPILLOMAVIRUS TYPE-16 E7 EPITOPE, American journal of obstetrics and gynecology, 175(6), 1996, pp. 1586-1593
Authors:
SALGALLER ML
POWDERLY JW
RIVOLTINI L
ROSENBERG SA
MARINCOLA FM
Citation: Ml. Salgaller et al., DIFFERENTIAL EXPRESSION AND CTL RECOGNITION OF THE MELANOCYTIC-LINEAGE-ASSOCIATED ANTIGENS MART-1 AND GP100 COMPLEXED WITH HLA-A2 IN MELANOCYTES COMPARED TO MELANOMA-CELLS, Molecular biology of the cell, 6, 1995, pp. 1030-1030
Authors:
CHEN PW
SALGALLER ML
ROSENBERG SA
MURRAY T
KSANDER BR
Citation: Pw. Chen et al., INCREASED EXPRESSION OF GENES ENCODING TUMOR-SPECIFIC ANTIGENS IN OCULAR MELANOMA - POTENTIAL TARGETS FOR IMMUNOTHERAPY, Investigative ophthalmology & visual science, 36(4), 1995, pp. 221-221
Authors:
RIVOLTINI L
KAWAKAMI Y
SAKAGUCHI K
SOUTHWOOD S
SETTE A
ROBBINS PF
MARINCOLA FM
SALGALLER ML
YANNELLI YR
APPELLA E
ROSENBERG SA
Citation: L. Rivoltini et al., INDUCTION OF TUMOR-REACTIVE CTL FROM PERIPHERAL-BLOOD AND TUMOR-INFILTRATING LYMPHOCYTES OF MELANOMA PATIENTS BY IN-VITRO STIMULATION WITH AN IMMUNODOMINANT PEPTIDE OF THE HUMAN-MELANOMA ANTIGEN MART-1, The Journal of immunology, 154(5), 1995, pp. 2257-2265
Authors:
SALGALLER ML
AFSHAR A
MARINCOLA FM
RIVOLTINI L
KAWAKAMI Y
ROSENBERG SA
Citation: Ml. Salgaller et al., RECOGNITION OF MULTIPLE EPITOPES IN THE HUMAN-MELANOMA ANTIGEN GP100 BY PERIPHERAL-BLOOD LYMPHOCYTES STIMULATED IN-VITRO WITH SYNTHETIC PEPTIDES, Cancer research, 55(21), 1995, pp. 4972-4979
Authors:
SALGALLER ML
WEBER JS
KOENIG S
YANNELLI JR
ROSENBERG SA
Citation: Ml. Salgaller et al., GENERATION OF SPECIFIC ANTIMELANOMA REACTIVITY BY STIMULATION OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES WITH MAGE-1 SYNTHETIC PEPTIDE, Cancer immunology and immunotherapy, 39(2), 1994, pp. 105-116
Authors:
SALGALLER ML
BEI R
SCHLOM J
POOLE DJ
ROBBINS PF
Citation: Ml. Salgaller et al., BACULOVIRUS RECOMBINANTS EXPRESSING THE HUMAN CARCINOEMBRYONIC ANTIGEN GENE, Cancer research, 53(9), 1993, pp. 2154-2161